Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: November 15, 2021 Report Code: GDME1232EPD-ST

Select Item

Glaucoma drainage devices or implants are small plastic devices that are surgically attached to the eye’s surface to improve or shunt the flow of aqueous drainage. This segment includes valved drainage devices and non-valved drainage devices.

The glaucoma drainage devices pipeline product report provides comprehensive information about the pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The glaucoma drainage devices pipeline report provides detailed insights of the pipeline products by a regulatory path including PMA, CE, 510(k), MDL, NIFDS, NMPA, ANVISA, BOPA, HAS, ICAC, INVIMA, Shonin, and TGA. Moreover, the report provides information about various pipeline products and their estimated approval dates.

What is the stage of development outlook of the glaucoma drainage devices pipeline products market?

As of November 2021, more than 2 pipeline products are under the early development stage whereas over 6 pipeline products are in the inactive stage. Apart from this, more than 3 pipeline products are in the clinical stage and 1 pipeline product is in the approval process. Moreover, 1 pipeline product has been approved and 1 pipeline product is in the pre-clinical stage.

What are the key segments in the glaucoma drainage devices pipeline products market?

The key segments in the glaucoma drainage devices pipeline products markets are drainage devices and non-valved drainage devices.

Non-Valved Drainage Devices

Non-Valved drainage devices have small structures which regulate the drainage of the eye. One unit refers to one non-valved drainage device.

Valved Drainage Devices

Valved implants are used to restrict the flow of fluid out of the eye. The drainage device has slits that help in the regulation of fluid flow out of the eye. One unit refers to one valved drainage device.

Glaucoma drainage devices pipeline products market, by segments

Glaucoma drainage devices pipeline products market, by segments

For more segment insights, download a free report sample

What are the key territories in the glaucoma drainage devices pipeline products market?

The US is the leading territory in the glaucoma drainage devices pipeline products market followed by Europe, Canada, Chile, China, Colombia, Costa Rica, Ecuador, El Salvador, Argentina, Australia, Brazil, India, Japan, Mexico, New Zealand, Singapore, South Korea, and Taiwan.

Glaucoma drainage devices pipeline products market, by territories

Glaucoma drainage devices pipeline products market, by territories

For more territory insights, download a free report sample

Which are the key companies in the glaucoma drainage devices pipeline products market?

The key companies in the glaucoma drainage devices pipeline products market are Alievio Inc, Avisi Technologies LLC, Geuder AG, InnFocus Inc, iVeena Delivery Systems Inc, Medtronic Plc, Meir Medical Center, Merz Anteis SA, MicroOptx Inc, OPKO Health Inc, Purdue University, Rheon Medical SA, Sheba Medical Center, Tel Aviv University, University of Colorado, and the University of Michigan.

Glaucoma drainage devices pipeline products market, by companies

Glaucoma drainage devices pipeline products market, by companies

To know more about key companies, download a free report sample

Market report scope

Key territories The US, Europe, Canada, Chile, China, Colombia, Costa Rica, Ecuador, El Salvador, Argentina, Australia, Brazil, India, Japan, Mexico, New Zealand, Singapore, South Korea, and Taiwan.
Key segments Non-Valved Drainage Devices and Valved Drainage Devices
Key companies Alievio Inc, Avisi Technologies LLC, Geuder AG, InnFocus Inc, iVeena Delivery Systems Inc, Medtronic Plc, Meir Medical Center, Merz Anteis SA, MicroOptx Inc, OPKO Health Inc, Purdue University, Rheon Medical SA, Sheba Medical Center, Tel Aviv University, University of Colorado, and the University of Michigan

Scope

  • Extensive coverage of the glaucoma drainage devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of glaucoma drainage devices and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage

  • Identify and understand important and diverse types of glaucoma drainage devices under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Alievio Inc
Avisi Technologies LLC
Geuder AG
InnFocus Inc
iVeena Delivery Systems Inc
Medtronic Plc
Meir Medical Center
Merz Anteis SA
MicroOptx Inc
OPKO Health Inc
Purdue University
Rheon Medical SA
Sheba Medical Center
Tel Aviv University
University of Colorado
University of Michigan

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Glaucoma Drainage Devices Overview 8

3 Products under Development 9

3.1 Glaucoma Drainage Devices – Pipeline Products by Stage of Development 9

3.2 Glaucoma Drainage Devices – Pipeline Products by Territory 10

3.3 Glaucoma Drainage Devices – Pipeline Products by Regulatory Path 12

3.4 Glaucoma Drainage Devices – Pipeline Products by Estimated Approval Date 13

3.5 Glaucoma Drainage Devices – Ongoing Clinical Trials 14

4 Glaucoma Drainage Devices – Pipeline Products under Development by Companies 15

4.1 Glaucoma Drainage Devices Companies – Pipeline Products by Stage of Development 15

4.2 Glaucoma Drainage Devices – Pipeline Products by Stage of Development 16

5 Glaucoma Drainage Devices Companies and Product Overview 17

5.1 Alievio Inc Company Overview 17

5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Avisi Technologies LLC Company Overview 18

5.2.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Geuder AG Company Overview 19

5.3.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 InnFocus Inc Company Overview 20

5.4.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 iVeena Delivery Systems Inc Company Overview 25

5.5.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Medtronic Plc Company Overview 26

5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Meir Medical Center Company Overview 27

5.7.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Merz Anteis SA Company Overview 28

5.8.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 MicroOptx Inc Company Overview 29

5.9.1 MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 OPKO Health Inc Company Overview 32

5.10.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Purdue University Company Overview 33

5.11.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Rheon Medical SA Company Overview 34

5.12.1 Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Sheba Medical Center Company Overview 37

5.13.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Tel Aviv University Company Overview 38

5.14.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 University of Colorado Company Overview 39

5.15.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 University of Michigan Company Overview 40

5.16.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40

6 Glaucoma Drainage Devices- Recent Developments 41

6.1 Jul 29, 2021: OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results 41

6.2 Jul 20, 2021: OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021 42

6.3 Feb 18, 2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results 42

7 Appendix 45

7.1 Methodology 45

7.2 About GlobalData 48

7.3 Contact Us 48

Table

Glaucoma Drainage Devices – Pipeline Products by Stage of Development 9

Glaucoma Drainage Devices – Pipeline Products by Territory 10

Glaucoma Drainage Devices – Pipeline Products by Regulatory Path 12

Glaucoma Drainage Devices – Pipeline Products by Estimated Approval Date 13

Glaucoma Drainage Devices – Ongoing Clinical Trials 14

Glaucoma Drainage Devices Companies – Pipeline Products by Stage of Development 15

Glaucoma Drainage Devices – Pipeline Products by Stage of Development 16

Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Camras Shunt – Product Status 17

Camras Shunt – Product Description 17

Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

VisiPlate – Product Status 18

VisiPlate – Product Description 18

Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 19

Microsystem Implant – Product Status 19

Microsystem Implant – Product Description 19

InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 20

PreserFlo MicroShunt – Product Status 20

PreserFlo MicroShunt – Product Description 21

InnFocus Inc – Ongoing Clinical Trials Overview 22

PreserFlo MicroShunt – A Prospective, Concurrent Controlled, Open-label, Multicenter Clinical Study to Assess the Long-term Safety of the PRESERFLO MicroShunt in Subjects with Primary Open-angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study 23

PreserFlo MicroShunt – Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas 23

PreserFlo MicroShunt – Evaluation of Minimal Invasive Glaucoma Surgery: Trabeculectomy Vs. Xen Vs. Preserflo Randomized Clinial Trial 23

PreserFlo MicroShunt – Intraocular Pressure after Preserflo /Innfocus Microshunt Vs Trabeculectomy: A Prospective, Randomized Control-trial (PAINT-Study) 24

PreserFlo MicroShunt – SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE) 24

PreserFlo MicroShunt – Vienna Preserflo Microshunt Cohort Study 24

iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 25

IVMED-70 – Product Status 25

IVMED-70 – Product Description 25

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 26

CellPlant Aqueous Stent – Product Status 26

CellPlant Aqueous Stent – Product Description 26

Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 27

Glaucoma Drainage Device – Product Status 27

Glaucoma Drainage Device – Product Description 27

Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 28

Drainage Viscoelastic Injectable Implant – Product Status 28

Drainage Viscoelastic Injectable Implant – Product Description 28

MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Brown Glaucoma Implant (BGI) – Product Status 29

Brown Glaucoma Implant (BGI) – Product Description 29

MicroOptx Inc – Ongoing Clinical Trials Overview 30

Brown Glaucoma Implant (BGI) – A Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of Beacon Aqueous Microshunt for Refractory Glaucoma: The Beacon Study 31

Brown Glaucoma Implant (BGI) – Early Evaluation of the Brown Glaucoma Implant in Patients Refractory to Drug Therapy in the European Union 31

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Aquashunt – Product Status 32

Aquashunt – Product Description 32

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 33

Smart Drainage Device – Glaucoma – Product Status 33

Smart Drainage Device – Glaucoma – Product Description 33

Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview 34

eyeWatch System – Product Status 34

eyeWatch System – Product Description 34

Rheon Medical SA – Ongoing Clinical Trials Overview 35

eyeWatch System – Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device 36

eyeWatch System – Randomized Control Trial of the eyeWatch System as a First-line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy 36

Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37

Toroidal Glaucoma Drainage Device – Product Status 37

Toroidal Glaucoma Drainage Device – Product Description 37

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 38

Glaucoma Implant – Product Status 38

Glaucoma Implant – Product Description 38

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 39

Aqueous Humor Micro-Bypass Shunt – Product Status 39

Aqueous Humor Micro-Bypass Shunt – Product Description 39

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40

Integrated Magnetoelastic Actuator – Product Status 40

Integrated Magnetoelastic Actuator – Product Description 40

Figures

Glaucoma Drainage Devices – Pipeline Products by Stage of Development 9

Glaucoma Drainage Devices – Pipeline Products by Territory 10

Glaucoma Drainage Devices – Pipeline Products by Regulatory Path 12

Glaucoma Drainage Devices – Pipeline Products by Estimated Approval Date 13

Frequently asked questions

Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Ophthalmic Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more